Why Babylon Health was more like Theranos than we thought

The latest stories trending on MedCity News.

Editor's Pick

Top Story Babylon Health's CEO 'Should Spend Some Time With Elizabeth Holmes' U.K. doctor David Watkins has been a public critic of Babylon Health for years, during which has received anonymous emails from Babylon employees saying that the company's AI is a sham. After Babylon collapsed, a former employee also publicly declared that the AI engine was faulty. As a longtime skeptic of Babylon's claims surrounding its technology, Watkins said that Ali Parsa, the company's CEO, belongs behind bars. Sponsored Content CEO of Providence Health Plan joins The Payer's Place Presented by HLTH and MedCity News Don Antonucci speaks on the recent friction in the marketplace between Payer's and Providers and what can be done to lessen that issue and prevent burnout.  He also addresses the future of payment models and the need to move from a fee-for-service model to value-based care. Watch the full interview here! What is the Future of Digital Therapeutics? Why, despite interest from regulators and some companies winning FDA clearances for their digital treatments, have digital therapeutics not gained traction? Learn more from this panel of experts: Rick Anderson, President, DarioHealth and Shira Butler, VP, Provider Growth and operations, Lin Health, plus one more speaker to be announced soon. Moderated by Aaron DeGagne, Research Analyst, Healthcare, PitchBook. Reserve Your Seat

Featured News

An Ounce of Prevention Isn't Enough To Treat Obesity If we want to support people with obesity, the weight loss debate must stop conflating obesity prevention with obesity treatment. Instead, we should focus on the tools that best solve the needs of people where they are – just as we would for cancer or diabetes – by making the most effective treatments possible available. How Hospitals Should Manage Cybersecurity Risks, Per Baptist Health's CIO As health systems shore up their defenses against cybercriminals, they should openly communicate with their third-party vendors about data security risks and work together to actively manage those risks. That was some of the advice given by Aaron Miri, Baptist Health's chief digital and information officer, during a Tuesday webinar. Walgreens, Pearl Health Strike Strategic Partnership To Advance Value-based Care Through a new partnership with Walgreens, Pearl Health will work with primary care providers by offering its technology and data insights to help them better their care and transition to value-based payment models. Walgreens is then providing prescription fulfillment, medication adherence, immunization and diagnostic testing services. Neuro Startup Arialys Raises $58M for Privilege of Tackling Brain Inflammation Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup's lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder. How 4 Mental Health Firms Want the DEA to Handle Virtual Prescribing of Controlled Substances Talkiatry, Array Behavioral Care, Iris Telehealth and Quartet Health sent a letter to the DEA asking for a special registration process that would allow for the prescribing of certain controlled medications via telemedicine. Healthcare Transformation: Boosting Data Quality, Tackling Burnout, and Charting the Future This on-demand webinar explores the impact of poor data quality and methods to improve patient data quality. It highlights technology that can improve workflows to help reduce workforce burnout. The Expanding Role of Benefit Consultants as Employers Look to Navigate Change This new report sheds light on how the benefit consultants' role has changed and details their perspective on the shifting employer healthcare landscape.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Andrew Trister, Chief Scientific Officer at Verily In this episode of MedCity Moves Podcast we were joined by Andrew Trister, who just became Verily's chief scientific officer. In this role, he will lead the company's population health initiatives and help advance its precision health strategies. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe